These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20650042)

  • 61. [Experimental herpes simplex keratitis in rabbits. Evaluation of pro-infectious effects of topical non-steroidal anti-inflammatory agents].
    Colin J; Bodin C; Malet F; Jouppe B; Bonne C; Chastel C
    J Fr Ophtalmol; 1989; 12(4):255-9. PubMed ID: 2628469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects and side effects of maternal administration of indomethacin for fetal tricuspid valve dysplasia.
    Hunter L; Vigneswaran TV; Pasupathy D; Callaghan N; Tenenbaum J; Zidere V; Simpson JM
    Ultrasound Obstet Gynecol; 2021 Aug; 58(2):322-323. PubMed ID: 32939846
    [No Abstract]   [Full Text] [Related]  

  • 63. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
    Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
    Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cochleotoxicity due to Mianserin hydrochloride.
    Marais J
    J Laryngol Otol; 1991 Jun; 105(6):475-6. PubMed ID: 2072020
    [No Abstract]   [Full Text] [Related]  

  • 65. [Treatment of gout].
    Forcada Gisbert J; Altaba Barceló A; Olivé Marqués A
    Aten Primaria; 1994 Sep; 14(4):752-3. PubMed ID: 7803683
    [No Abstract]   [Full Text] [Related]  

  • 66. Sensorineural hearing loss associated with intrathecal vancomycin.
    Klibanov OM; Filicko JE; DeSimone JA; Tice DS
    Ann Pharmacother; 2003 Jan; 37(1):61-5. PubMed ID: 12503934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methadone associated long term hearing loss and nephrotoxicity; a case report and literature review.
    Ghasemi S; Izadpanahi S; Yaghoubi MA; Brent J; Mehrpour O
    Subst Abuse Treat Prev Policy; 2019 Nov; 14(1):48. PubMed ID: 31694678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An open assessment of tenoxicam (Tilcotil) in the treatment of acute gout in general practice.
    Waterworth RF; Waterworth SM
    N Z Med J; 1987 Dec; 100(837):744-5. PubMed ID: 3502545
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathophysiology of furosemide ototoxicity.
    Rybak LP
    J Otolaryngol; 1982 Apr; 11(2):127-33. PubMed ID: 7042998
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide.
    Cianfrone G; Pentangelo D; Cianfrone F; Mazzei F; Turchetta R; Orlando MP; Altissimi G
    Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):601-36. PubMed ID: 21796866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Noninvasive Vagus Nerve Stimulation for Treatment of Indomethacin-Sensitive Headaches.
    Tso AR; Marin J; Goadsby PJ
    JAMA Neurol; 2017 Oct; 74(10):1266-1267. PubMed ID: 28846758
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Indomethacin induced psychosis.
    Tharumaratnam D; Bashford S; Khan SA
    Postgrad Med J; 2000 Nov; 76(901):736-7. PubMed ID: 11060173
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3).
    Hartnick CJ; Cohen AF; Smith RV
    Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):640-2. PubMed ID: 9270425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treating gout in the presence of cardiac failure.
    Jolobe O
    Practitioner; 1994 Jun; 238(1539):489-90. PubMed ID: 8208665
    [No Abstract]   [Full Text] [Related]  

  • 76. Risks and benefits of drugs used in the management and prevention of gout.
    Conaghan PG; Day RO
    Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study.
    Henry D; Page J; Whyte I; Nanra R; Hall C
    Br J Clin Pharmacol; 1997 Jul; 44(1):85-90. PubMed ID: 9241101
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Summaries for Patients. Oral Prednisolone in the Treatment of Acute Gout.
    Ann Intern Med; 2016 Apr; 164(7):. PubMed ID: 26902107
    [No Abstract]   [Full Text] [Related]  

  • 79. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.